Radiofrequency ablation combined with transarterial chemoembolization for liver metastases from gastrointestinal cancers

Abstract

Transarterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) has been reported to be effective for local control of different-sized hepatocellular carcinomas. However, it is unclear if these benefits could also be applicable to different-sized liver metastases from gastrointestinal cancers. The aim of this study was to evaluate the outcomes of TACE combined with RFA for liver metastases from gastrointestinal cancers. In this study, we retrospectively analyzed clinical data of 19 consecutive patients who had a total of 26 liver metastatic lesions from gastrointestinal cancers and underwent RFA followed by first-time TACE treatment. The tumor recurrence, overall survival rate and procedure-related complications were evaluated. Moreover, patients’ demographics and tumor characteristics were analyzed to determine their impact on the outcomes. The technical success of TACE plus RFA was achieved with 2 major procedure-related complications found. The mean follow-up was 21.3 months. The total 1-, 2-, and 3-year survival rate was 89.4%, 52.6%, and 35.1%, respectively. It was found that the tumor size and the ratio of enhancement area were significant factors that influenced the overall survival. In conclusion, patients with gastrointestinal cancer-derived liver metastatic lesions of smaller size and larger enhancement area are considered appropriate candidates for TACE plus RFA.

Keywords

radiofrequency ablation / transarterial chemoembolization / liver metastases / gastrointestinal cancer / overall survival

References

[1] KoshariyaM, JagadRB, KawamotoJ, et al. . An update and our experience with metastatic liver disease. Hepatogastroenterology, 2007, 54(80): 2232-2239 PMID: 18265640

[2] ManfrediS, LepageC, HatemC, et al. . Epidemiology and management of liver metastasis from colorectal cancer. Ann Surg, 2006, 244(2): 254-259 PMID: 16858188 PMCID: 1602156

[3] CirocchiR, TrastulliS, BoselliC, et al. . Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev, 2012, 6: CD006317 PMID: 22696357

[4] QianJ. Interventional therapies of unresectable liver metastases. J Cancer Res Clin Oncol, 2011, 137(12): 1763-1772 PMID: 21909952

[5] MahnkenAH, PereiraPL, de BaèreT. Interventional oncologic approaches to liver metastases. Radiology, 2013, 266(2): 407-430 PMID: 23362094

[6] MorimotoM, NumataK, KondouM, et al. . Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer, 2010, 116(23): 5452-5460 PMID: 20672352

[7] VeltriA, MorettoP, DoriguzziA, et al. . Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol, 2006, 16(3): 661-669 PMID: 16228211

[8] KagawaT, KoizumiJ, KojimaS, et al. . Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer, 2010, 116(15): 3638-3644 PMID: 20564097

[9] FongZV, PalazzoF, NeedlemanL, et al. . Combined hepatic arterial embolization and hepatic ablation for unresectable colorectal metastases to the liver. Am Surg, 2012, 78(11): 1243-1248 PMID: 23089443

[10] ChenJ, TangZ, DongX, et al. . Radiofrequency ablation for liver metastasis from gastric cancer. Eur J Surg Oncol, 2013, 39(7): 701-706 PMID: 23597495

[11] HyunchulR, HyoK L, DongilChoi. Current status of radiofrequency ablation of hepatocellular carcinoma. World J Gastrointest Surg, 2010, 2(4): 128-136

[12] ShibataT, IsodaH, HirokawaY, et al. . Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment. Radiology, 2009, 252(3): 905-913 PMID: 19567647

[13] KudoM. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology, 2010, 78: 113-124 PMID: 20616593

[14] BonomoG, DellaV P, MonfardiniL, et al. . Combined therapies for the treatment of technically unresectable liver malignancies: bland embolization and radiofrequency thermal ablation within the same session. Cardiovasc Intervent Radiol, 2012, 35(6): 1372-1379 PMID: 22271077

[15] LiaoM, HuangJ, ZhangT, et al. . Transarterial chemoembolization in combination with local therapies for hepatocellular carcinoma: a meta-analysis. PLoS One, 2013, 8(7): e68453 PMID: 23844203 PMCID: 3701086

[16] WolpinBM, MayerRJ. Systemic treatment of colorectal cancer. Gastroenterology, 2008, 134(5): 1296-1310 PMID: 18471507 PMCID: 2528832

[17] PawlikTM, DelmanKA, VautheyJN, et al. . Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl, 2005, 11(9): 1086-1092 PMID: 16123959

[18] KimYS, RhimH, LimHK, et al. . Hepatic infarction after radiofrequency ablation of hepatocellular carcinoma with an internally cooled electrode. J Vasc Interv Radiol, 2007, 18(9): 1126-1133 PMID: 17804775